The method of administration and dose of the drug is prescribed by a doctor. Since the drug is prescribed for the treatment of Fabry disease, the drug is taken under medical supervision. This allows you to monitor the metabolic reactions of the body to the drug.
The recommended dose of Fabrazyme is 1 mg per kg of body weight. The drug is administered to the patient every two weeks in the form of an infusion or intravenous injection. At the same time, the initial infusion rate should not exceed 0.25 mg / min. After a while, the speed of administration of the drug can be increased, but gradually.
If the drug is prescribed to patients with renal insufficiency, then, if side effects occur, the dose of the drug is not subject to correction. The drug is very rarely prescribed to children, since the study of the effect of pharabzyme on children has not been conducted, so the drug is taken after the doctor's permission and under his supervision.